Viewing Study NCT06560333


Ignite Creation Date: 2025-12-25 @ 2:49 AM
Ignite Modification Date: 2026-05-19 @ 10:09 PM
Study NCT ID: NCT06560333
Status: WITHDRAWN
Last Update Posted: 2025-12-18
First Post: 2024-08-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: iSGLT2 Inhibitor and a iDPP -4 Inhibitor in Treatment of Type 2 Diabetes Mellitus in Patients Treated With Metformin (TRIAD)
Sponsor: Eurofarma Laboratorios S.A.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: EF186
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators